These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3120466)

  • 61. [Hemoglobinopathy in the county of Copenhagen].
    Birgens HS; Karle H; Guldberg P; Güttler F
    Ugeskr Laeger; 1997 Jun; 159(25):3934-9. PubMed ID: 9214066
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Postmarital follow-up survey on high risk patients subjected to premarital screening program in Saudi Arabia.
    Al Sulaiman A; Saeedi M; Al Suliman A; Owaidah T
    Prenat Diagn; 2010 May; 30(5):478-81. PubMed ID: 20440737
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Newborn bloodspot results: predictive value of screen positive test for thalassaemia major.
    Streetly A; Latinovic R; Henthorn J; Daniel Y; Dormandy E; Darbyshire P; Mantio D; Fraser L; Farrar L; Will A; Tetlow L
    J Med Screen; 2013 Dec; 20(4):183-7. PubMed ID: 24277229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effectiveness of one tube osmotic fragility screening in detecting beta-thalassaemia trait.
    Kattamis C; Efremov G; Pootrakul S
    J Med Genet; 1981 Aug; 18(4):266-70. PubMed ID: 7277419
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mass spectrometric analysis of unknown haemoglobin fractions identified by high-performance liquid chromatography in an antenatal screening programme.
    Griffin M; Eyre J; Dack S; Wright J
    J Clin Pathol; 2015 May; 68(5):388-90. PubMed ID: 25694443
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The parental perspective of thalassaemia in Bangladesh: lack of knowledge, regret, and barriers.
    Hossain MS; Mahbub Hasan M; Petrou M; Telfer P; Mosabbir AA
    Orphanet J Rare Dis; 2021 Jul; 16(1):315. PubMed ID: 34271949
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.
    Shokrani M; Terrell F; Turner EA; Aguinaga MD
    Ann Clin Lab Sci; 2000 Apr; 30(2):191-4. PubMed ID: 10807164
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-benefit analysis of a national thalassaemia prevention programme in Israel.
    Ginsberg G; Tulchinsky T; Filon D; Goldfarb A; Abramov L; Rachmilevitz EA
    J Med Screen; 1998; 5(3):120-6. PubMed ID: 9795870
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neonatal screening for sickling hemoglobinopathies in South Carolina: can the promise be fulfilled?
    Pai GS; Houser PM
    J S C Med Assoc; 1987 May; 83(5):243-5. PubMed ID: 3474474
    [No Abstract]   [Full Text] [Related]  

  • 70. Diagnostic applications of newborn screening for α-thalassaemias, haemoglobins E and H disorders using isoelectric focusing on dry blood spots.
    Jindatanmanusan P; Riolueang S; Glomglao W; Sukontharangsri Y; Chamnanvanakij S; Torcharus K; Viprakasit V
    Ann Clin Biochem; 2014 Mar; 51(Pt 2):237-47. PubMed ID: 23901141
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A national screening policy for sickle cell disease and thalassaemia major for the United Kingdom. Questions are left after two evidence based reports.
    Streetly A
    BMJ; 2000 May; 320(7246):1353-4. PubMed ID: 10818007
    [No Abstract]   [Full Text] [Related]  

  • 72. Sickle cell disease and thalassaemia.
    Fuller J
    Practitioner; 1993 Apr; 237(1525):344-9. PubMed ID: 8351277
    [No Abstract]   [Full Text] [Related]  

  • 73. Prenatal prevention for severe thalassemia disease at Srinagarind Hospital.
    Ratanasiri T; Charoenthong C; Komwilaisak R; Changtrakul Y; Fucharoen S; Wongkham J; Kleebkaow P; Seejorn K
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S87-93. PubMed ID: 17725145
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Delivering genetic screening to the community.
    Modell B
    Ann Med; 1997 Dec; 29(6):591-9. PubMed ID: 9562530
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The prevalence of sickle cell disease in Abu-AL-Khasib district of southern Iraq.
    Alkasab FM; Al-Alusi FA; Adnani MS; Alkafajei AM; Al-Shakerchi NH; Noori SF
    J Trop Med Hyg; 1981 Apr; 84(2):77-80. PubMed ID: 7218407
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prenatal diagnosis of sickle syndromes in India: dilemmas in counselling.
    Colah R; Surve R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Satoskar P; Mohanty D
    Prenat Diagn; 2005 May; 25(5):345-9. PubMed ID: 15906420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Iranian national program for the prevention of thalassemia and prenatal diagnosis : mandatory premarital screening and legal medical abortion.
    Fallah MS; Samavat A; Zeinali S
    Prenat Diagn; 2009 Dec; 29(13):1285-6. PubMed ID: 19953581
    [No Abstract]   [Full Text] [Related]  

  • 78. Sickle cell disease and thalassaemia antenatal screening programme in England over 10 years: a review from 2007/2008 to 2016/2017.
    Weil LG; Charlton MR; Coppinger C; Daniel Y; Streetly A
    J Clin Pathol; 2020 Apr; 73(4):183-190. PubMed ID: 31771971
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Premarital screening for beta-thalassaemia in Southern Iran: options for improving the programme.
    Karimi M; Jamalian N; Yarmohammadi H; Askarnejad A; Afrasiabi A; Hashemi A
    J Med Screen; 2007; 14(2):62-6. PubMed ID: 17626703
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prenatal diagnosis of beta-thalassaemia and sickle cell anaemia in Turkey.
    Tüzmen S; Tadmouri GO; Ozer A; Baig SM; Ozçelik H; Başaran S; Başak AN
    Prenat Diagn; 1996 Mar; 16(3):252-8. PubMed ID: 8710780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.